Additionally, NEAT1, acetyl-CoA carboxylase (ACC), and fatty acid synthase (FAS) mRNA are all significantly enhanced in both in vivo and in vitro models of NAFLD [88]. This evidence concerns the gene NEAT1 and metabolic dysfunction-associated steatotic liver disease.